Welcome to PsychU!

2020 BIPOC Mental Health Month Toolkit

Each July, Mental Health America (MHA) aims to shed light on the multitude of mental health experiences of Black, Indigenous, People of Color (BIPOC) communities, and others that face disproportionate… Read More

COVID-19 & Your Mental Health

Provided with permission from Mental Health America, a PsychU Supporting Organization. To learn more about MHA, please visit their website at http://www.mentalhealthamerica.net. Read More

Disclosing To Others Fact Sheet

Ideally, the people around you will understand your illness and encourage you. But the important people in your life might not know much about mental illness. They may want to… Read More

Resident’s Corner Challenge, Dr. Caitlin Wise

Dr. Caitlin Wise relays her pharmacy residency experience. As an avid dancer, Dr. Wise shares similar challenges between conducting research and performing on-stage. Caitlin Wise, PharmD, is a PGY1 Managed… Read More

COVID-19 Resource & Information Guide

The National Alliance on Mental Illness (NAMI) Offers These Tips For People With Mental Illness: For anyone who is unsure about attending therapy sessions outside the home, especially those who… Read More

Mental Health In The COVID-19 Era

The news about COVID-19 is relentless: an ever-escalating number of confirmed cases, portents of economic meltdown, ominous images of barren public spaces. Most people find it stressful to be surrounded… Read More

Coronavirus & Mental Well-Being

News is everywhere about the swift spread of coronavirus and the deaths in its wake. There is much we do not know about the virus or the disease it causes,… Read More

Utilizing PsychU As A Resident

Dr. Pankaj Manocha, MD shares his perspective as a member of PsychU during his fellowship. Dr. Manocha attended his first PsychU live event discussing treatment implications for bi-polar depression, major… Read More

How Do Bipolar Disorder Type I & Type II Differ?

Traditionally, bipolar disorder type II (BDII) has been thought to be less severe—and less disabling—than bipolar disorder type I (BDI). Experts believe this characterization might be attributed to the fact… Read More

Telepsychiatry: Implementation & Best Practices

Dr. Mehdi Qalbani discusses his experience providing telepsychiatry in the Information Age. Topics include regulatory concerns, practice guidelines, and web-side manner when working remotely. Mehdi Qalbani, MD, MSPH, is the… Read More

Sleep In Behavioral Health

In this podcast, Sana Johnson-Quijada, MD, highlights the importance of sleep in overall behavioral health and discusses goals for better sleep quality. Sleep impacts hormones and neurotransmitters. Implementing and maintaining… Read More

Lean Into Mindfulness

What do mindfulness and organizational change have in common? More than you might think. At The 2019 OPEN MINDS Executive Leadership Retreat, Monica Oss closed the retreat with her keynote,… Read More

Suicide Awareness & Prevention

Dr. Nicole Meade discusses suicide awareness and prevention, a topic that is extremely important to our community. Dr. Meade examines suicide statistics and terminology, such as why the phrase “committed… Read More

Meet The Treatment Team: Physician Assistant

In this interview, Catherine Judd, MS, PA-C, CAQ-Psy, discusses the role a physician assistant plays in the mental health team. Physician assistants have a broad-base, primary care medical background in… Read More

How To Avoid Digital Culture Shock

Change of any kind can be difficult, but any change that meets with resistance from any level of an organization can quickly become impossible—something we’ve written about before (see Challenges… Read More

Managing Your Team To ‘Tech Savvy’

Our team has written before about the importance of technology adoption to future competitive advantage and sustainability in the field. There is technology to facilitate better clinical decision making (see… Read More

Addiction By The Numbers

How should addiction treatment programs be evaluated? That was the focus of the session, Quality Measurement In Addiction Treatment: Advancing Adoption Of Best Practices, at The 2019 OPEN MINDS Management… Read More

Ready To Collect More Cash?

Copayments and deductibles used to be a small issue. The $1 here or $20 there. Not anymore. Consumers now pay 30% of total health care costs.1 There are now health… Read More

Brief Risk Questionnaire© (BRQ)

The Brief Risk Questionnaire© (BRQ) is an opioid risk screening tool found to offer a good alternative to doing a clinical interview (see Brief Risk Interview© (BRI) https://psychu.org/brief-risk-interview-bri/). The tool… Read More

Hamilton Depression Rating Scale (HAM-D)

The Hamilton Depression Rating Scale (HAM-D; HRSD; HDRS), designed in 1960, has become one of the most widely utilized rating scales intended to assess depression disorder symptom severity and change.… Read More

Digital Interventions In Psychiatry: Part 2

In this short presentation, hear from Fatima Sadat, PharmD, as she reviews different types of digital technology that may provide tools for the assessment or management of mental health treatment.… Read More

Wellness Tracker

This tool is a simple checklist for consumers to complete in the waiting room. Consumers can easily check off how they’ve been feeling and write down issues or concerns they’d… Read More

Meet The Treatment Team: Psychologists

In this interview, Elizabeth DiNapoli, PhD, Medical Science Liaison, sat down to discuss the role a psychologist may play on the treatment team of individuals with mental illness. Meet the other… Read More

The Catch-22 Of Charity Care

The question of whether tax-exempt non-profit health care organizations provide enough “community benefit” has turned into one of our more popular conversations this year, following my coverage of the latest… Read More

Treatment For Bipolar Disorder: A Resource For Providers

This provider resource presents the importance of bipolar treatment, suggested treatment goals and considerations, an overview of psychosocial interventions and medication therapy, and considerations for monitoring treatment response. Frameworks resources… Read More

Can Uber & Lyft Answer The No-Show Problem?

A couple weeks ago, I looked at the pending revolution in non-emergency health care transportation (NEMT). It’s an important revolution because Medicaid alone spent an estimated $2.9 billion on NEMT… Read More

Opioid Addiction By The Numbers

Last week, we covered the recent $3.3 billion in Congressional appropriations to address opioid addiction in the United States (see How Far Does $3.3 Billion Go?). The figure $3.3 billion… Read More

Getting Ready For The Era Of Telehealth

There has been a substantial increase in the number of organizations using telehealth technologies. For organizations over $25 million in revenue, 44% are using telehealth technologies, compared to 15% just… Read More

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

Key Messages Long-term follow-up studies of specialized early intervention (SEI) programs following discontinuation have been contradictory. OPUS II was the first prolonged SEI study beyond three years. OPUS II reported… Read More

Uber & Lyft Enter The Health Care Market

Transportation has always been a health care issue. In 2013, Medicare spent $1.2 billion for non-emergency health care transportation (NEMT), and Medicaid spent $1.5 billion. Most states report that utilization… Read More

Biomarkers For Depression: An Interview With Robin Nelson, MD

During this interview, Robin Nelson, MD discusses the article summary “Biomarkers For Depression: Recent Insights, Current Challenges & Future Prospects” which can be viewed here: https://psychu.org/biomarkers-depression-recent-insights-current-challenges-future-prospects/. Read More

Where Have All The Psychiatrists Gone?

I wrote recently about how the rise in the number of consumers who have health insurance hasn’t translated directly into access to care in mental health. I realize that there… Read More

Patient Health Questionnaire (PHQ)

The Patient Health Questionnaire (PHQ) is a self-administered scale for assessing five of the most common types of mental disorders presenting in medical populations: depressive, anxiety, somatoform, alcohol use, and… Read More

Brief Patient Health Questionnaire (Brief PHQ)

The Brief Patient Health Questionnaire (Brief PHQ) is a self-administered scale for assessing depressive disorders and panic disorders. It is derived from the depression questions within the full Patient Health… Read More

Suicide Awareness In Primary Care

In this short interview, Marla Moses, FNP, PMHNP, PsychU Primary Care Providers’ Corner Section Editor and Owner of IN Moses Mental Health in Indianapolis, IN, shared her perspective on suicide… Read More

Patient Health Questionnaire 15 (PHQ-15)

The Patient Health Questionnaire 15 is a self-administered 15-item scale to measure somatic symptoms, with questions from the Patient Health Questionnaire (PHQ). The PHQ family of measures, including abbreviated and… Read More

Opioid Risk Tool© (ORT)

The Opioid Risk Tool© (ORT) is a five-question, self-administered assessment that can be completed within 5 minutes and should be utilized on a patient’s initial visit. It assesses the patient… Read More

Alcohol Use Disorders Identification Test (AUDIT-C)

The Alcohol Use Disorders Identification Test (AUDIT-C) is a brief alcohol screen that reliably identifies patients who are hazardous drinkers or who have active alcohol use disorders. The AUDIT-C contains… Read More


The Mini-Cog™ is a 3-minute instrument that can increase detection of cognitive impairment in older adults. It can be used effectively after brief training in both health care and community-based… Read More

Generalized Anxiety Disorder 7-Item Scale (GAD-7)

The Generalized Anxiety Disorder 7-Item Scale (GAD-7) is a self-administered 7-item anxiety scale initially developed to diagnose generalized anxiety disorder. The GAD-7 also proved to have sensitivity and specificity as… Read More

Payer, Provider, Partner

We’re at the stage where the field is moving from talk to action on value-based reimbursement (VBR) and health plan/provider partnerships. While our January survey found only 40% of specialty… Read More

Be Ethical Or Be Regulated

While everyone complains about regulation, many times the purpose of regulation makes perfect sense. I think this is the case with new regulations in Florida focused on addiction treatment providers.… Read More

Comorbid Medical Illness In Bipolar Disorder

Key Messages This study measured rates of medical illnesses in patients with bipolar disorder (BD) and assessed potential associations between medical disease burden and the clinical course of BD. Compared… Read More

Lifestyle Changes Are Effective For Preventing Dementia

Healthier lifestyles are associated with declining prevalence of cognitive impairment and dementia. Furthermore, specific lifestyle changes are effective for preventing dementia, including increasing education in early life, increasing physical activity… Read More

Mood Disorder Questionnaire (MDQ)

The Mood Disorder Questionnaire is a brief self-administered tool to screen (not diagnose) for bipolar disorder. It takes about five minutes to complete and should be followed by a comprehensive… Read More

Neurobiology Of Risk For Bipolar Disorder

Key Messages Tools that would facilitate early diagnosis, intervention, and prevention of new bipolar episodes may be of benefit to patients with bipolar disorder or who may develop bipolar disorder… Read More

Smartphone Applications For Mental Health

Key Messages As little research has been done to characterize the information available to users of mental health-related smartphone applications (apps), the authors performed a content analysis of descriptions of… Read More

Neuroinflammation & Psychiatric Illness

Key Messages Multiple lines of evidence support the role of neuroinflammatory processes in the pathogenesis of psychiatric illnesses. Neuropsychiatric disorders are frequently found among patients with autoimmune conditions; in addition,… Read More

Welcome To The Residents’ Corner!

John Luo, MD, Section Editor of PsychU’s Residents’ Corner, welcomes residents, students and early career psychiatric professionals to the Residents’ Corner. Dr. Luo is a Health Sciences Clinical Professor of… Read More

Opinions On The Treatment Of MDD

As part of PsychU’s growth and prominence in the mental health community, three large panel presentations were conducted in New York City, Raleigh, NC, and the Los Angeles area discussing… Read More

A ‘Perfect Storm’ For Telemental Health

Right now, we’re seeing a perfect storm for growth in telemental health, and it’s due to a combination of three factors: a workforce shortage of psychiatrists, consistently good outcomes for… Read More

Theories Of Bipolar Disorder Pathophysiology

This video is part 2 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews some of the potential molecular (eg, genetics), cellular (eg, ion dysregulation,… Read More

PTSD & Trauma In Bipolar Disorder

What role can trauma or PTSD play in bipolar disorder diagnosis? The prevalence of post-traumatic stress disorder (PTSD) in patients with bipolar disorder is higher than in the general population.1… Read More

Rating Scales For Bipolar Disorder

What rating scales can be used to screen for, or assess symptoms of, bipolar disorder? Scales in bipolar disorder include screening scales such as the Mood Disorder Questionnaire (MDQ),1 which… Read More

Insulin: The Overlooked Neuromodulator

Interview with Thomas Stewart, MD, an associate clinical professor of psychiatry at Yale University School of Medicine and a consultation-liaison psychiatrist at Yale New Haven Hospital. Read More

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This video provides an overview of some of the different signaling… Read More

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This video reviews neurotransmitter receptor subtypes, provides an overview of neurotransmitter… Read More

Immunology Of Major Depression

Key Messages Evidence has indicated that the inflammatory system may play a key role in major depression (MD). Characteristics of immune activation have been observed in MD, and several cytokines… Read More

Pharmacokinetics: The Basics

During this recorded presentation, Jacquelyn Canning, PharmD, BCPP, provided a brief overview of the basics of pharmacokinetics. The presentation’s objectives included: Explain the concept and clinical relevance of pharmacokinetics Describe… Read More

Depression, Serotonin & Tryptophan

Key Messages Research into the pathophysiology of depression has moved beyond the serotonergic system to examine the interplay of wider body systems and processes. This article reviewed recent literature pertaining… Read More

Basics In Psychopharmacology

This video is part 1 of the 3-part series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. The video starts with an introduction to the organization and… Read More

Fraud Front & Center

“If you worked for me, you’d be fired this afternoon.” That was a quote from Representative Chris Collins (R-N.Y.), speaking to Dr. Shantanu Agrawal, deputy administrator and director of the… Read More

Depression: From Psychopathology To Pathophysiology

Key Messages This review aimed to provide a coherent view of the underlying psychopathology and pathophysiology of depression by integrating findings from cognitive psychology and neurobiology. Cognitive psychology has developed… Read More

MACRA – Who Are The Winners & Losers?

Signed on April 16, 2015 by President Obama, the Medicare Access and CHIP Reauthorization Act (MACRA) provides funding for the Children’s Health Insurance Program (CHIP) through 2017 and makes sweeping… Read More

Solving For Engagement With Technology

Poor patient engagement is a well-known obstacle in the pursuit of better health care outcomes – an obstacle with mounting costs in our value-based market. The consumers who are actively… Read More

Schizophrenia—A Medical Psychiatric Syndrome

Thomas Stewart, MD Associate Clinical Professor of Psychiatry Yale University School of Medicine Abundant evidence underlines the importance of aggressive interventions in newly diagnosed patients with schizophrenia leading to reduced… Read More

Who Is Your Chief Experience Officer?

Over the years, I have seen some creative executive titles – “Director of First Impressions,” “Creator of Opportunities,” “Chief Amazement Officer,” and “Happiness Advocate” spring to mind. But a new title… Read More

Does Cost Savings = Quality?

A few weeks ago, we covered a report issued by the Idaho Office of Performance Evaluations which found that in the two years since the Idaho Medicaid program moved mental health services… Read More

Pay-For-Value In Action

The shift from fee-for-service (FFS) reimbursement to value-based contracting is certainly a work in progress. Some markets, some payers, and some services are more in progress than others. But one… Read More

The Evolving Psychopharmacology Of Major Depressive Disorder

During this recorded presentation, David Scheiderer, MD, provided a brief overview of the psychopharmacology of major depressive disorder. Key points included: Monoamine Imbalance Theory Alternative Hypotheses Theoretical Receptor-Mediated Physiological Effects… Read More

This Is A Headline You Want To Avoid

For any executive in the health and human service field, this is a headline you want to avoid – “12 Hospitals You Might Want to Avoid.” Of course, if you… Read More

Keys To Marketing To Millennial Consumers

Millennials – the approximately 80 million people 18 to 35 years old (born between the early 1980s to the early 2000s) – do things differently. They donate differently, they expect… Read More

Treating Depression: What To Do & When To Do It

Interview with Professor Roger McIntyre, University of Toronto, Canada In my clinical experience, one in two patients with MDD does not reach our therapeutic objective. These patients with suboptimal response… Read More

Not Magic But Logic

An interview with Professor Michael Thase, Director of the Mood and Anxiety Program at the University of Pennsylvania’s Perelman School of Medicine, USA Depression is a state of negative expectations… Read More

The Importance Of Norepinephrine In Depression

Key Messages The hypothesis that impaired serotonin (5-HT) and/or norepinephrine (NE) neurotransmission underlies depressive disorders continues to be central to treatment approaches. Several lines of evidence support a role for… Read More

Early Intervention In Psychosis

During this recorded presentation, Diana Perkins, MD, provided a brief overview of the role of early intervention in patients with schizophrenia. Key points included: Medical rationale for early intervention Potential… Read More

The Urgent Care Opportunity

“Urgent care” for behavioral health is in demand. Why? Mental health admissions are still proving a big proportion of hospitalizations. In 2010, expenses for hospital inpatient stays accounted for nearly one-third of… Read More

The Neurobiology Of Relapse In Schizophrenia

Key Messages Relapse rates among patients with first-episode schizophrenia have been reported to exceed 80% within 5 years. This review of the neurophysiology of schizophrenia relapse suggests that dopamine may… Read More

Metabolic Wellness Considerations In Schizophrenia

During this presentation, Sloan Manning, MD, provided a brief overview metabolic issues and wellness considerations in schizophrenia. Key points included: Life expectancy is substantially shorter for patients with schizophrenia compared… Read More